2021

September 20, 2021

Ongoing Trial: The INDICATE trial is testing ways to personalize treatment for men with prostate cancer that returns after surgery

The study will assess if PET/CT scans can help identify patients who may have better outcomes from adding customized therapy to standard-of-care treatment